AuthorCitation

Clinical Worsening in Reversible Cerebral Vasoconstriction Syndrome (P05.217)

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.p05.217

Successful Intravenous Thrombolysis Followed by Mechanical Thrombectomy in a Patient with Cerebral Ischemia and a Dural AV Fistula: A Case Report (P01.253)

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.p01.253

Clinical Reasoning: A woman with subacute progressive confusion and gait instability

Neurology | July 29, 2014 | Volume: 83 | Issue: 5 | Pages: No page available

10.1212/wnl.0000000000000648 | PMID 25074896

Clinical Reasoning: A 55-year-old man with weight loss, ataxia, and foot drop

Neurology | June 17, 2014 | Volume: 82 | Issue: 24 | Pages: No page available

10.1212/wnl.0000000000000525 | PMID 24960835

Antithrombotic selection and risk factor management in ischemic stroke and transient ischemic attack

Neurosurgical Focus | January 1, 2014 | Volume: 36 | Issue: 1 | Pages: E10

10.3171/2013.10.focus13402 | PMID 24380476

In addition to appropriate antithrombotic therapy, the identification and treatment of modifiable ischemic stroke risk factors can reduce the likelihood of recurrent stroke. Neurosurgeons should be knowledgeable of the specific risk factors and general recommendations for ischemic stroke, as they may play a significant role in the management options for patients with intracranial and extracranial atherosclerotic disease. The authors of this article review the indications for and selection of antithrombotics in patients with cerebral ischemia. In addition, the identification and secondary prevention of select risk factors are discussed.

Clinical Worsening in Reversible Cerebral Vasoconstriction Syndrome

JAMA Neurology | November 4, 2013 | Volume: 71 | Issue: 1 | Pages: 68

10.1001/jamaneurol.2013.4639 | PMID 24190097